Hello friends,
today the company gave the answers we were looking for between the lines of the Appendix4C statement !!!.
everything is perfectly synchronized in timing in coordination with the market and ergo:
Pilcher announces that the AGM will be held on June 18th; we know that as a rule the Annual meeting to shareholders must be notified 20 working days before the AGM, so it will be released on April 18th. what fits perfectly in this program is the question of the last options available to executives with the right to convert from May 7, 2018 for 50% and for the remaining portion bound to the achievement of $ 3.22 or more maintained for 30 working days . with a calendar in hand, from 7 May for the following 30 working days we arrive at 18 June 2018.
I believe that all this can not be pure randomness, so it is obvious from logic that today has been defined all the agreement or strategy that brings Neuren to the next steps or by financing or merging. the company has taken all the time necessary to go face to face with the shareholders and informs that the intellectual property of Trofinetide is further increased with the grant of the Japanese patent. this is the clear message that the work of these long months has been concentrated in defining a real value to be transferred black and white with those who have been interested for some years.
very difficult now that the price per share declines below $ 2.96 in the next sessions; on the contrary, I remain in pleasant expectation that from 7 May onwards the market will raise the bar above $ 3.22.
good luck to all
NEU Price at posting:
$3.05 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)